Insider filing · EWTX
Kevin Koch
President and CEO
profile →
Edgewise Therapeutics, Inc.
EWTX · Healthcare · 23 filings in 24 months
ticker →
Kevin Koch sold $259K of Edgewise Therapeutics (EWTX)
Executed Feb 5 2025, disclosed Feb 7 2025, 2 days later.
Value, as filed
$259K
8,636 sh × $30.03
Executed
Feb 5 2025
the trade date, as filed
Disclosed
Feb 7 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
KKKevin Koch (President and CEO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Edgewise Therapeutics, Inc. (EWTX). The largest single filing was $745K of EWTX (17,058 sh across 2 lots, as filed), executed Aug 12.
The name
EWTXHealthcare · Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle dis…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Kevin Koch in EWTX
EWTXSALE
Edgewise Therapeutics, Inc.
$745K17,058 sh across 2 lots
Exec Aug 12
Filed Aug 14 · 4:52 PM ET EWTXSALE Edgewise Therapeutics, Inc. $107K
7,972 sh × $13.39
Exec Aug 12 2025
Filed Aug 14 2025 · 5:30 PM ET